Development of an oral cancer recurrence mouse model after surgical resection

International Journal of Oncology

Volumn 36, Issue 4, 2010, Pages 849-855

  Behren, Andreas ^a,d   Kamenisch, York ^b   Muehlen, Sabrina ^a   Flechtenmacher, Christa ^a   Haberkorn, Uwe ^a   Hilber, Hermann ^b   Myers, Jeffrey N ^c   Bergmann, Zazie ^a   Plinkert, Peter Karl ^a   Simon, Christian ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

Enhanced green fluorescent protein; Head and neck squamous cell carcinoma; Metastasis; Mouse model; Oral cancer; Recurrence

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INFILTRATION; CANCER INVASION; CANCER MODEL; CANCER RECURRENCE; CANCER SURGERY; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MICROSCOPY; MICROSURGERY; MOUSE; MOUTH CARCINOMA; NONHUMAN; ORAL SQUAMOUS CELL CARCINOMA; ORAL SURGERY; ORTHOTOPIC TRANSPLANTATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GREEN FLUORESCENT PROTEINS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ORAL SURGICAL PROCEDURES; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 77949288273     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000562     Document Type: Article

References (29)

1. Stewart BWKP (ed): World Cancer Report. IARC-Press, Lyon, 2003.
2. Dobrossy L: Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 1: 9-17, 2005.
3. Bissell MJ, Labarge MA: Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 1: 17-23, 2005.
4. Liu T, Ding Y, Xie W, Li Z, Bai X, Li X, Fang W, Ren C, Wang S, Hoffman RM and Yao K: An imageable metastatic treatment model of nasopharyngeal carcinoma. Clin Cancer Res 13: 3960-3967, 2007.
5. Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, Teraishi F, Kyo S, Mizuguchi H, Hashimoto Y, Urata Y, Tanaka N and Fujiwara T: In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med 10: 1213-1219, 2006.
6. Moshitch-Moshkovitz S, Tsarfaty G, Kaufman DW, Stein GY, Shichrur K, Solomon E, Sigler RH, Resau JH, Vande Woude GY and Tsarfaty I: In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met. Neoplasia 8: 353-363, 2006.
7. Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR and Hoffman RM: Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 5: 1534-1540, 2002.
8. Hasegawa S, Yang M, Chishima T, Miyagi Y, Shimada H, Moossa AR and Hoffman RM: In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis. Cancer Gene Ther 7: 1336-1340, 2000.
9. Kaneko K, Yano M, Tsujinaka T, Morita S, Taniguchi M, Fujiwara Y, Doki Y, Inoue M, Shiozaki H and Monden M: Establishment of a visible peritoneal micrometastatic model from a gastric adenocarcinoma cell line by green fluorescent protein. Int J Oncol 16: 893-898, 2000.
10. Paris S, Chauzy C, Martin-Vandelet N, Delpech B, Thiberville L, Martin JP and Diarra-Mehrpour M: A model of spontaneous lung metastases visualised in fresh host tissue by green fluorescent protein expression. Clin Exp Metastasis 10: 817-822, 1999.
11. Yang M, Jiang P, Sun FX, Hasegawa S, Baranov E, Chishima T, Shimada H, Moossa AR and Hoffman RM: A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 4: 781-786, 1999.
12. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S and Kohn D: Immune response to green fluorescent protein: implications for gene therapy. Gene Ther 7: 1305-1312, 1999.
13. Hoffman RM: Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Metastasis Rev 3: 271-277, 1998.
14. Moore A, Sergeyev N, Bredow S and Weissleder R: A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread. Invasion Metastasis 4: 192-197, 1998.
15. Yang M, Hasegawa S, Jiang P, Wang X, Tan Y, Chishima T, Shimada H, Moossa AR and Hoffman RM: Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res 19: 4217-4221, 1998.
16. Chishima T, Yang M, Miyagi Y, Li L, Tan Y, Baranov E, Shimada H, Moossa AR, Penman S and Hoffman RM: Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA 21: 11573-11576, 1997.
17. Hoffman RM: Imaging tumor angiogenesis with fluorescent proteins. APMIS 7-8: 441-449, 2004.
18. Hoffman R: Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol 9: 546-556, 2002.
19. Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR and Hoffman RM: Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 10: 2042-2047, 1997.
20. Chishima T, Miyagi Y, Wang X, Baranov E, Tan Y, Shimada H, Moossa AR and Hoffman RM: Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin Exp Metastasis 5: 547-552, 1997.
21. Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S and Hoffman RM: Whole-body optical imaging of green fluorescent protein expressing tumors and metastases. Proc Natl Acad Sci USA 97: 1206-1211, 2000.
22. MacDonald TJ, Tabrizi P, Shimada H, Zlokovic BV and Laug WE: Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. Neurosurgery 6: 1437-1442, 1998.
23. Myers JN, Holsinger FC, Jasser SA, Bekele BN and Fidler IJ: An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 1: 293-298, 2002.
24. Kademani D, Bell RB, Bagheri S, Holmgren E, Dierks E, Potter B and Homer L: Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 11: 1599-1605, 2005.
25. Dinesman A, Haughey B, Gates G and Aufdemorte T: Development of a new in vivo model for head and neck cancer. Laryngoscope 766-774, 1990.
26. Simon C, Nemechek AJ, Boyd D, O'Malley BW Jr, Goepfert H, Flaitz CM and Hicks MJ: An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion. Laryngoscope 11: 1686-1691, 1998.
27. Simon C, Hicks MJ, Nemechek AJ, Mehta R, O'Malley BW Jr, Goepfert H, Flaitz CM and Boyd D: PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer 9: 1412-1419, 1999.
28. Dunne AA, Schmidt A, Kuropkat C, Ramaswamy A, Schulz S and Werner JA: The auricular VX2 carcinoma - an animal model for sentinel node concept. In Vivo 5: 457-461, 2003.
29. Sapundzhiev N, Dunne AA, Ramaswamy A and Werner JA: The auricular VX2 carcinoma: feasibility of complete tumor resection. Anticancer Res 6B: 4209-4214, 2005.